Growth hormone associated with treatment efficacy of immune checkpoint inhibitors in gastric cancer patients

BACKGROUND: Immune checkpoint inhibitors (ICIs) combined with chemotherapy have been widely employed to improve the outcome of gastric cancer patients. In the present study, the impact of posttreatment growth hormone (GH) levels on the treatment efficacy of ICIs for advanced gastric cancer (AGC) pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yue, Ji, Zhengzheng, Li, Jiasong, Zhang, Shasha, Wu, Chensi, Zhang, Ruixing, Guo, Zhanjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395680/
https://www.ncbi.nlm.nih.gov/pubmed/36016614
http://dx.doi.org/10.3389/fonc.2022.917313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395680/
https://www.ncbi.nlm.nih.gov/pubmed/36016614
http://dx.doi.org/10.3389/fonc.2022.917313

Ejemplares similares